WHO’s Unprecedented Appeal: Suspend Sale & Slaughter Of Live Wild Mammals In Food Markets To Head Off New Virus Risks 13/04/2021 Elaine Ruth Fletcher In an unusually bold step for the cautious global health agency, the World Health Organization has called upon countries to suspend the sale of captured live wild mammals in food markets as an emergency measure. The appeal follows on the publication of a report by a WHO-convened international team examining the origins of the SARS-CoV2 […] Continue reading -> Pakistan Threatens Health Workers: Get the Chinese-donated vaccine or get fired! 16/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Pakistan authorities are threatening to fire healthcare workers who refuse to be vaccinated with the Chinese-donated SinoPharm COVID-19 vaccine. In a harshly worded letter, , the Directorate of Health Services in Sindh warns frontline health care workers that reluctance to get the jab will result in “strict disciplinary action” including suspension or dismissal […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> WHO’s Legal Mandate Is Weak In Responding To COVID-19 Emergency; But Changes Are Up To Member States 23/04/2020 Svĕt Lustig Vijay In the wake of the COVID-19 pandemic, there could be “a window of opportunity… that would be suicidal to miss” to revise the International Health Regulations that govern countries’ behaviour during health emergencies, said Gian Luca Burci, former World Health Organization head legal counsel and now professor of international law, at a panel hosted by […] Continue reading -> Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pakistan Threatens Health Workers: Get the Chinese-donated vaccine or get fired! 16/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – Pakistan authorities are threatening to fire healthcare workers who refuse to be vaccinated with the Chinese-donated SinoPharm COVID-19 vaccine. In a harshly worded letter, , the Directorate of Health Services in Sindh warns frontline health care workers that reluctance to get the jab will result in “strict disciplinary action” including suspension or dismissal […] Continue reading -> Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> WHO’s Legal Mandate Is Weak In Responding To COVID-19 Emergency; But Changes Are Up To Member States 23/04/2020 Svĕt Lustig Vijay In the wake of the COVID-19 pandemic, there could be “a window of opportunity… that would be suicidal to miss” to revise the International Health Regulations that govern countries’ behaviour during health emergencies, said Gian Luca Burci, former World Health Organization head legal counsel and now professor of international law, at a panel hosted by […] Continue reading -> Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> WHO’s Legal Mandate Is Weak In Responding To COVID-19 Emergency; But Changes Are Up To Member States 23/04/2020 Svĕt Lustig Vijay In the wake of the COVID-19 pandemic, there could be “a window of opportunity… that would be suicidal to miss” to revise the International Health Regulations that govern countries’ behaviour during health emergencies, said Gian Luca Burci, former World Health Organization head legal counsel and now professor of international law, at a panel hosted by […] Continue reading -> Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO’s Legal Mandate Is Weak In Responding To COVID-19 Emergency; But Changes Are Up To Member States 23/04/2020 Svĕt Lustig Vijay In the wake of the COVID-19 pandemic, there could be “a window of opportunity… that would be suicidal to miss” to revise the International Health Regulations that govern countries’ behaviour during health emergencies, said Gian Luca Burci, former World Health Organization head legal counsel and now professor of international law, at a panel hosted by […] Continue reading -> Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Posts navigation Older posts